BCLS II Investco LP 13D and 13G filings for NewAmsterdam Pharma Company N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-17 5:35 pm Purchase | 2024-12-13 | 13D | NewAmsterdam Pharma Company N.V. NAMS | BCLS II Investco LP | 10,719,110 13.000% | 5,342,754 (+99.38%) | Filing |
| 2024-03-01 4:30 pm Unchanged | 2024-02-28 | 13D | NewAmsterdam Pharma Company N.V. NAMS | BCLS II Investco LP | 5,376,356 6.000% | 0 (Unchanged) | Filing |
| 2023-06-13 5:04 pm Purchase | 2023-06-09 | 13D | NewAmsterdam Pharma Company N.V. NAMS | BCLS II Investco LP | 5,376,356 6.600% | 1,376,356 (+34.41%) | Filing |
| 2022-12-02 4:24 pm Purchase | 2022-11-22 | 13D | NewAmsterdam Pharma Company N.V. NAMS | BCLS II Investco LP | 4,000,000 4.900% | 4,000,000 (New Position) | Filing |